[1] . Coderre JA et al. J Nucl Med,1986; 27:1157-1164.
[2] . Reisfeld RA. Monoclonal antibodies as probes for structure and function of human melauoma-assoc; ated antigens. In:Veronsi U et al. editors,Cutaneous Melanoma,London; Academic Press,1987:374.
[3] . Ferrone S et al. Ann NY Acad Sci,1989:l.
[4] . Siccardi AG et al. Cancer Res,1986; 46:4817-4822.
[5] . Carrasquillo JA et al. J Nucl Med,1988; 29; 39-47.
[6] . Scheidhauer K et al. Nucl Med Commun,1988; 9:669-679.
[7] . Nelp WB et al. J Nucl Med,1987; 28:34-41.
[8] . Matzka S et al. J Nucl Med,1989; 30:390-397.
[9] . Murray JL et al. J Nucl Med,1987; 28:25-33.
[10] . Buraggi CL et al. Int J Kadiat Appl 1ns-trum,Part B,1989; 16(6):629-632.
[11] . Yokoyama K et al. J Nucl Med,1990; 33:202-210.
[12] . Yokoyama K et al. J Nucl Med,1986; 27:1043.
[13] . Otsuka FL et al. Int I Radjat Appl 1ns-trum,Part B,1987; 14(3):243-249.
[14] . Paik CH et al. J Nucl Med,1989; 30:1693-1701.
[15] . Halpern SE et al. Radiology,1988; 168:529-536.
[16] . Hnatowich DJ. Sem Nucl Med,1990; 20(1):80-91.
[17] . Fritzberg AR et al. J Nucl Med,1986; 27:957-958.
[18] . Fritzberg AR. Advances in 99mTc-lalteling ox antibodies. Presented at the symposium on "Monoclonal Antibodies in Nuclear Medi-cine",Mayl-3,1986; Nuklear Medizin,December,1986:25.
[19] . Eary JF et al. J Nucl Med,1989; 30(1):25-32.
[20] . Krizan Z et al. Cancer Res,1985; 45:4904-4909.
[21] . Ziai MR et al. Cancer Res,1987; 47:2474-2480.
[22] . Taylor A et al. J Nucl Med,1988; 29:329-337.
[23] . Murray JL et al. Cancer Rey,1988; 48:4417-4422.